Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of preeclampsia, according to a study in ...
Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the first ...
The first agreement grants a license to a pioneering therapeutics company focused on developing a novel iPSC-based treatment for neurological disease. The partnership will leverage Pluristyx's ...
For many couples facing infertility, medicine offers a range of solutions. But for men with non-obstructive azoospermia (NOA)—a genetic condition where sperm production stalls—options remain limited.
A freshman Idaho lawmaker wants to ban most COVID-19 shots for the next decade, with a bill rooted in misconceptions about vaccines that thrived during the pandemic. The bill from Sen. Brandon Shippy, ...
As per SNS Insider Research, The DNA Manufacturing Market growth is driven by plasmid DNA demand, biopharma innovation, and advancements in DNA-based vaccine production.Austin, Nov. 07, 2025 (GLOBE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback